Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 3
2022 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapy for head and neck cancer: Present and future.
Fasano M, Corte CMD, Liello RD, Viscardi G, Sparano F, Iacovino ML, Paragliola F, Piccolo A, Napolitano S, Martini G, Morgillo F, Cappabianca S, Ciardiello F. Fasano M, et al. Among authors: paragliola f. Crit Rev Oncol Hematol. 2022 Jun;174:103679. doi: 10.1016/j.critrevonc.2022.103679. Epub 2022 Apr 6. Crit Rev Oncol Hematol. 2022. PMID: 35395371 Free article. Review.
How Immunotherapy Has Changed the Continuum of Care in Hepatocellular Carcinoma.
Martini G, Ciardiello D, Paragliola F, Nacca V, Santaniello W, Urraro F, Stanzione M, Niosi M, Dallio M, Federico A, Selvaggi F, Della Corte CM, Napolitano S, Ciardiello F, Martinelli E. Martini G, et al. Among authors: paragliola f. Cancers (Basel). 2021 Sep 21;13(18):4719. doi: 10.3390/cancers13184719. Cancers (Basel). 2021. PMID: 34572944 Free PMC article. Review.
Immunotherapy in colorectal cancer: is the long-awaited revolution finally happening?
Arrichiello G, Poliero L, Borrelli C, Paragliola F, Nacca V, Napolitano S, Corte CMD, Martini G, Martinelli E. Arrichiello G, et al. Among authors: paragliola f. Cancer Treat Res Commun. 2021;28:100442. doi: 10.1016/j.ctarc.2021.100442. Epub 2021 Aug 3. Cancer Treat Res Commun. 2021. PMID: 34391139 Free article. Review.
Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy.
Fasano M, Della Corte CM, Viscardi G, Di Liello R, Paragliola F, Sparano F, Iacovino ML, Castrichino A, Doria F, Sica A, Morgillo F, Colella G, Tartaro G, Cappabianca S, Testa D, Motta G, Ciardiello F. Fasano M, et al. Among authors: paragliola f. Ther Adv Med Oncol. 2021 Mar 9;13:1758835920949418. doi: 10.1177/1758835920949418. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33767760 Free PMC article. Review.
Beyond N staging in colorectal cancer: Current approaches and future perspectives.
Arrichiello G, Pirozzi M, Facchini BA, Facchini S, Paragliola F, Nacca V, Nicastro A, Canciello MA, Orlando A, Caterino M, Ciardiello D, Della Corte CM, Fasano M, Napolitano S, Troiani T, Ciardiello F, Martini G, Martinelli E. Arrichiello G, et al. Among authors: paragliola f. Front Oncol. 2022 Jul 18;12:937114. doi: 10.3389/fonc.2022.937114. eCollection 2022. Front Oncol. 2022. PMID: 35928863 Free PMC article. Review.
Real-World Activity and Safety of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients with Refractory Metastatic Colorectal Cancer.
Arrichiello G, Perrone A, Napolitano S, Martini G, De Falco V, Incoronato P, Laterza MM, Facchini G, Famiglietti V, Nacca V, Paragliola F, Napolitano R, Suarato G, Nicastro A, Martinelli E, Ciardiello D, Ciardiello F, Troiani T. Arrichiello G, et al. Among authors: paragliola f. Target Oncol. 2022 Nov;17(6):635-642. doi: 10.1007/s11523-022-00916-8. Epub 2022 Oct 14. Target Oncol. 2022. PMID: 36239883 Free PMC article.
11 results